Frontiers
US$ 28.23
glp 1 agonist bone density Frontiers GLP-1 Agonists and Orthopedic Surgery:
Description
In vitro receptor binding studies explored structural requirements for GLP-1 and GLP-1/GIP chimeric peptides regarding their affinity towards the GLP-1 receptor in insulinoma cell lines (44, 45)
We also need to evaluate other tools, such as the FRAX and trabecular bone score (TBS) in this specific population
Also, the adverse cardiovascular safety in clinical trials before 2008 was evaluated based on populations that were not necessarily at high risk of cardiovascular disease and the follow-up duration was relatively short (usually less than 12 months)
Chequin et al
ELIXA Investigators
